Centre for Aging + Brain Health Innovation (CABHI) study finds that Pillcheck helped identify medications that were not effective or posed a high risk of side effects for long-term care residents. The revised medication plans significantly improved the management of depression and chronic pain and reduced the risk of complications...
A randomized controlled trial showed that people suffering from depression and anxiety recovered faster when their medications were optimized using Pillcheck pharmacogenetics testing (also known as pharmacogenomics or PGx testing). The study evaluated the impact of pharmacogenomics-guided prescribing versus standard antidepressant treatment of depression and anxiety in three large community...
How COVID is forcing the accelerated evolution of health benefits services and the role of pharmacogenetics in helping plan members get the right medications to support recovery from a wide variety of pandemic-related health issues. Click the image below to read the full article or download the PDF. Benefits And Pensions Monitor...
Pillcheck preferred retail pricing now available to all Canada Life health insurance customers January 7, 2021, Toronto, ON – GeneYouIn Inc., a leader in personalized medicine, today announced it is growing its relationship with Canada Life, a leading health insurer. The new deal will give preferred retail pricing to all of...
The new program builds on the successful introduction of Pillcheck pharmacogenetics by many insurers seeking to impact the frequency and duration of Short-Term and Long-Term disability claims. Now the same rigorously evaluated, secure service is available to plans and benefit advisors on a subscription basis or as a private purchase...
Study shows that over 80% could benefit from a pharmacogenetic test and improve treatment. Many older adults, especially those in elder care, are at risk of harmful medication-related side effects. Often, the issues are preventable with an easy pharmacogenetic test and a medication review by an expert pharmacist. A recent study involving Pillcheck...
About half of all prescription medications are ineffective. You read that right. HALF of us are taking meds that don’t work for us for a variety of reasons. People respond to medications differently. In fact, 95% of us have variations that determine how we respond to certain drugs and the subtleties of...
Genetic tests can provide predictive insights into many domains, such as ancestry, inherited predisposition to disease or your body’s ability to respond to a certain medication treatment – pharmacogenetics. Veronika Litinski, Pillcheck’s CEO, discusses the benefits for plans and the context for successfully implementing precision medicine with plan members. See the...
By enhancing the ability of doctors to select prescription drugs that better interact with an individual’s inherited genetic variations, pharmacogenetics may hold a key to improving medical experiences for members and reducing plan costs. See the full article here
This article in Benefits Quarterly for first quarter 2017 describes how methods of personalized medicine — specifically, pharmacogenetic (PGx) testing— can benefit private health plans, benefits managers, care providers and consumers alike. The authors cover pharmacogenomics as a science and also introduce an innovative way to optimize drug treatments. The...
